DWD-20069-05149
4 vaccinations
7 coded responses
49 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 558 / MN
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
-
2021-01-27
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: Good · HeadacheFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Vibratory sense increased — Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessFree text: Vibratory sensation of lips, chest, abdomen, thighs, armsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — day 14, dose 1MedDRA: Erythema, Injection site erythema, Injection site pruritus — Feeling: GoodFree text: Expanding redness, rash- like, itching at injection site. Onset one week after injection, duration continues today 2 weeks post injection however now improving with decreased redness and itching. Demarcated circular ring persists with mild erythema.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
-
2021-02-26
Dose 2 — Moderna
- 2021-02-26
-
2021-02-27
Survey response — days 1–6 daily, dose 2MedDRA: Dysstasia, Hyperacusis — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficult to stand up. Sounds loud and irritating.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: WeaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-03-03
- 2021-03-04
- 2021-03-05
-
2021-03-12
Survey response — day 14, dose 2MedDRA: Rash — Feeling: GoodFree text: Rash on chest and backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
- 2021-03-26
- 2021-04-04
- 2021-04-09
- 2021-05-28
- 2021-08-27
-
2021-10-29
Dose 3 — Moderna
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
-
2022-04-12
Dose 4 — Pfizer-BioNTech
- 2022-04-18
- 2022-04-19
- 2022-04-26
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-05-24
-
2022-07-12
Survey response — 3 months, dose 4MedDRA: Bronchial irritation, Chills, Cough, Fatigue, Oropharyngeal pain, SARS-CoV-2 test positive, Sinus congestion, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID tested positive 05/27/22. Sore throat, sinus congestion, sneezing, cough, chills, fatigue duration 10 days. Residual sneezing, cough, bronchial irritation for more than a month.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-26 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-04-12 | Pfizer-BioNTech | No |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Dizziness
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Vibratory sensation of lips, chest, abdomen, thighs, arms
Release 4 — day 14, dose 1
Symptoms: Expanding redness, rash- like, itching at injection site. Onset one week after injection, duration continues today 2 weeks post injection however now improving with decreased redness and itching. Demarcated circular ring persists with mild erythema. cut off by CDC
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Difficult to stand up. Sounds loud and irritating.
Systemic reaction (other): Weakness
Release 5 — day 14, dose 2
Symptoms: Rash on chest and back
Release 12 — 3 months, dose 4
Symptoms: COVID tested positive 05/27/22. Sore throat, sinus congestion, sneezing, cough, chills, fatigue duration 10 days. Residual sneezing, cough, bronchial irritation for more than a month.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchial irritation | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dysstasia | ✓ | ✓ | ✓ |
| SRO | Hyperacusis | ✓ | ✓ | ✓ |
| SRO | Vibratory sense increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release